128 related articles for article (PubMed ID: 9041060)
1. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ
J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
[TBL] [Abstract][Full Text] [Related]
2. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ
J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
[TBL] [Abstract][Full Text] [Related]
3. Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats.
Jee WS; Lin BY; Ma YF; Ke HZ
J Bone Miner Res; 1995 Jun; 10(6):963-70. PubMed ID: 7572321
[TBL] [Abstract][Full Text] [Related]
4. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats.
Lin BY; Jee WS; Ma YF; Ke HZ; Kimmel DB; Li XJ
Bone; 1994; 15(5):489-96. PubMed ID: 7980959
[TBL] [Abstract][Full Text] [Related]
5. Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure.
Tang LY; Jee WS; Ke HZ; Kimmel DB
J Bone Miner Res; 1992 Sep; 7(9):1093-104. PubMed ID: 1414502
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC
J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
[TBL] [Abstract][Full Text] [Related]
7. Skeletal effects of constant and terminated use of sodium risedronate in ovariectomized rats.
Li QN; Liang NC; Huang LF; Wu T; Hu B; Mo LE
Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):160-3. PubMed ID: 10374643
[TBL] [Abstract][Full Text] [Related]
8. Effects of daily administration of prostaglandin E2 and its withdrawal on the lumbar vertebral bodies in male rats.
Ke HZ; Jee WS
Anat Rec; 1992 Oct; 234(2):172-82. PubMed ID: 1416104
[TBL] [Abstract][Full Text] [Related]
9. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
[TBL] [Abstract][Full Text] [Related]
10. Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats.
Pan Z; Jee WS; Ma YF; McOsker JE; Li XJ
Bone; 1995 Oct; 17(4 Suppl):291S-296S. PubMed ID: 8579931
[TBL] [Abstract][Full Text] [Related]
11. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats.
Chen HK; Jee WS; Ma YF; Pan Z; McOsker JE; Li XJ
Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY
Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone.
Ma Y; Jee WS; Yuan Z; Wei W; Chen H; Pun S; Liang H; Lin C
J Bone Miner Res; 1999 Mar; 14(3):439-48. PubMed ID: 10027909
[TBL] [Abstract][Full Text] [Related]
14. Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats.
Liang HH; Ma YF; Jee WS; Pan Z; Setterberg RB; McOsker JE; Li XJ
Bone; 1995 Oct; 17(4 Suppl):335S-339S. PubMed ID: 8579936
[TBL] [Abstract][Full Text] [Related]
15. Loss of prostaglandin E2-induced extra cortical bone after its withdrawal in rats.
Jee WS; Ke HZ; Li XJ
Bone Miner; 1992 Apr; 17(1):31-47. PubMed ID: 1581704
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
[TBL] [Abstract][Full Text] [Related]
17. Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats.
Li QN; Jee WS; Ma YF; Ke HZ; Xie H; Huang LF; Liang NC
Bone; 1995 Oct; 17(4 Suppl):261S-266S. PubMed ID: 8579926
[TBL] [Abstract][Full Text] [Related]
18. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
[TBL] [Abstract][Full Text] [Related]
19. Skeletal effects of constant and terminated use of risedronate on cortical bone in ovariectomized rats.
Li QN; Liang NC; Huang LF; Wu T; Hu B; Mo LE
J Bone Miner Metab; 1999; 17(1):18-22. PubMed ID: 10084397
[TBL] [Abstract][Full Text] [Related]
20. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
